Therapeutic Strategies to Maximize the Clinical Benefit of EGFR TKIs in Advanced NSCLC: Current Data and Future Directions

Featuring an on-demand Webcast and downloadable slideset this program equips clinicians with evidence-based strategies to optimize the care of patients with EGFR-mutated advanced NSCLC in the first-line setting and beyond.

Share

Program Content

Activities

EGFR TKIs in Advanced NSCLC
Therapeutic Strategies to Maximize the Clinical Benefit of EGFR TKIs in Advanced NSCLC: Current Data and Future Directions
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: October 23, 2018

Expires: October 22, 2019

Activities

Frontline EGFR TKIs
The Evolving Landscape of Frontline EGFR TKIs
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 27, 2018

Expires: September 26, 2019

Recurrent <i>EGFR</i>+ NSCLC
Recurrent EGFR Mutation–Positive NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 27, 2018

Expires: September 26, 2019

Emerging Treatment Options
Where to Next? Future Directions in Treatment Strategies for EGFR-Mutated NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 27, 2018

Expires: September 26, 2019

Faculty

cover img faculity

Shirish Gadgeel, MD

Professor
Division of Hematology/Oncology
Department of Internal Medicine
University of Michigan
Ann Arbor, Michigan

cover img faculity

Heather Wakelee, MD

Associate Professor of Medicine, Oncology
Department of Medicine/Oncology
Stanford University/Stanford Cancer Institute
Stanford, California

cover img faculity

Helena Yu, MD

Associate Professor
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Pfizer, Inc.